Anti‐cancer drugs targeting the NADH ‐binding site of VDAC rewire channel electrophysiology and partially suppress cation selectivity

Documenti analoghi

• Potency of agarose gel‐supported lipid bilayers for electrophysiologic analysis of channel pores formed by Bacillus thuringiensis insecticidal proteins
  di: Tsubasa Okuda, et al.
  Pubblicazione: (2025)
• The flavodiiron protein from Syntrophomonas wolfei has five domains and acts both as an NADH:O2 or an NADH:H2O2 oxidoreductase
  di: Maria C. Martins, et al.
  Pubblicazione: (2024)
• Cyclic nucleotide signaling as a drug target in retinitis pigmentosa
  di: Katri Vainionpää, et al.
  Pubblicazione: (2025)
• Detection of NADH and NADPH levels in vivo identifies shift of glucose metabolism in cancer to energy production
  di: Elena V. Potapova, et al.
  Pubblicazione: (2024)
• Inhibition of mitochondrial NADH :ubiquinone oxidoreductase by spinning oscillating magnetic fields causes toxicity in cancer cells
  di: Shashank Hambarde, et al.
  Pubblicazione: (2026)